Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11890282 Method of reducing pulmonary exacerbations in respiratory disease patients

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Ralph Grosswald0

Sanjeev Ahuja0

Gregory S. Duncan0

Eric B. Springman0

Date of Patent

February 6, 2024

0

Patent Application Number

171455860

Date Filed

January 11, 2021

0

Patent Citations

US Patent 8246935 Dry powder formulations

0

US Patent 9315509 Diamine derivatives as inhibitors of leukotriene A4 hydrolase

0

US Patent 10350197 Methods of inhibiting leukotriene A4 hydrolase

0

US Patent 9820974 Methods of inhibiting leukotriene A4 hydrolase

0

US Patent 10898484 Method of reducing pulmonary exacerbations in respiratory disease patients

0

US Patent 7597897 Medicinal compositions and method for the preparation thereof

0

US Patent 7915298 Compounds and methods for leukotriene biosynthesis inhibition

0

Patent Primary Examiner

Rei Tsang Shiao

0

CPC Code

0

Patent abstract

Described are methods of reducing pulmonary exacerbations and methods of treating cystic fibrosis, including methods of reducing pulmonary inflammation, comprising administration of an LTA4h inhibitor.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11890282 Method of reducing pulmonary exacerbations in respiratory disease patients

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.